MAPK3 and non-small cell lung carcinoma: LINC00467 was overexpressed in NSCLC, and knockdown of LINC00467 upregulated miR-125a-3p to decrease cisplatin (DDP) resistance in NSCLC cells via inhibiting SIRT6 and inactivating the ERK1/2 signaling pathway [46].